These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109. Using Surface Plasmon Resonance to Study SH2 Domain-Peptide Interactions. Watson GM; Gunzburg MJ; Wilce JA Methods Mol Biol; 2023; 2705():199-210. PubMed ID: 37668975 [TBL] [Abstract][Full Text] [Related]
110. Genomic organization and control of the grb7 gene family. Lucas-Fernández E; García-Palmero I; Villalobo A Curr Genomics; 2008 Mar; 9(1):60-8. PubMed ID: 19424485 [TBL] [Abstract][Full Text] [Related]
111. Enhancing the Bioactivity of Bicyclic Peptides Targeted to Grb7-SH2 by Restoring Cell Permeability. Sturre NP; Colson RN; Shah N; Watson GM; Yang X; Wilce MCJ; Price JT; Wilce JA Biomedicines; 2022 May; 10(5):. PubMed ID: 35625882 [TBL] [Abstract][Full Text] [Related]
112. The intracellular domains of the EphB6 and EphA10 receptor tyrosine pseudokinases function as dynamic signalling hubs. Liang LY; Roy M; Horne CR; Sandow JJ; Surudoi M; Dagley LF; Young SN; Dite T; Babon JJ; Janes PW; Patel O; Murphy JM; Lucet IS Biochem J; 2021 Sep; 478(17):3351-3371. PubMed ID: 34431498 [TBL] [Abstract][Full Text] [Related]
113. Store-Operated Calcium Entry: Shaping the Transcriptional and Epigenetic Landscape in Pancreatic Cancer. Kutschat AP; Johnsen SA; Hamdan FH Cells; 2021 Apr; 10(5):. PubMed ID: 33919156 [TBL] [Abstract][Full Text] [Related]
114. STIM1 Mediates Calcium-Dependent Epigenetic Reprogramming in Pancreatic Cancer. Kutschat AP; Hamdan FH; Wang X; Wixom AQ; Najafova Z; Gibhardt CS; Kopp W; Gaedcke J; Ströbel P; Ellenrieder V; Bogeski I; Hessmann E; Johnsen SA Cancer Res; 2021 Jun; 81(11):2943-2955. PubMed ID: 33436389 [TBL] [Abstract][Full Text] [Related]
115. Grb7, a Critical Mediator of EGFR/ErbB Signaling, in Cancer Development and as a Potential Therapeutic Target. Chu PY; Tai YL; Shen TL Cells; 2019 May; 8(5):. PubMed ID: 31083325 [TBL] [Abstract][Full Text] [Related]
116. Insight into the Selectivity of the G7-18NATE Inhibitor Peptide for the Grb7-SH2 Domain Target. Watson GM; Lucas WAH; Gunzburg MJ; Wilce JA Front Mol Biosci; 2017; 4():64. PubMed ID: 29018805 [TBL] [Abstract][Full Text] [Related]
117. Septin oligomerization regulates persistent expression of ErbB2/HER2 in gastric cancer cells. Marcus EA; Tokhtaeva E; Turdikulova S; Capri J; Whitelegge JP; Scott DR; Sachs G; Berditchevski F; Vagin O Biochem J; 2016 Jun; 473(12):1703-18. PubMed ID: 27048593 [TBL] [Abstract][Full Text] [Related]
118. Binding and function of phosphotyrosines of the Ephrin A2 (EphA2) receptor using synthetic sterile α motif (SAM) domains. Borthakur S; Lee H; Kim S; Wang BC; Buck M J Biol Chem; 2014 Jul; 289(28):19694-703. PubMed ID: 24825902 [TBL] [Abstract][Full Text] [Related]
119. Preparation of crystals for characterizing the Grb7 SH2 domain before and after complex formation with a bicyclic peptide antagonist. Ambaye ND; Gunzburg MJ; Traore DA; Del Borgo MP; Perlmutter P; Wilce MC; Wilce JA Acta Crystallogr F Struct Biol Commun; 2014 Feb; 70(Pt 2):182-6. PubMed ID: 24637751 [TBL] [Abstract][Full Text] [Related]
120. Preparation and crystallization of the Grb7 SH2 domain in complex with the G7-18NATE nonphosphorylated cyclic inhibitor peptide. Yap MY; Wilce MC; Clayton DJ; Perlmutter P; Aguilar MI; Wilce JA Acta Crystallogr Sect F Struct Biol Cryst Commun; 2010 Dec; 66(Pt 12):1640-3. PubMed ID: 21139214 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]